PA
TYRA icon

Perceptive Advisors’s Tyra Biosciences TYRA Stock Holding History

Perceptive Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-511,226
Closed -$12M – 119
2024
Q3 		$12M Sell
511,226
-496,141
-49% -$10.4M 0.25% 68
2024
Q2 		$16.1M Buy
1,007,367
+338,208
+51% +$5.82M 0.39% 58
2024
Q1 		$11M Buy
669,159
+309,159
+86% +$5.07M 0.19% 75
2023
Q4 		$4.99M Hold
360,000
– – 0.11% 76
2023
Q3 		$4.96M Hold
360,000
– – 0.17% 70
2023
Q2 		$6.13M Sell
360,000
-134,403
-27% -$1.95M 0.18% 74
2023
Q1 		$7.95M Hold
494,403
– – 0.23% 70
2022
Q4 		$3.76M Hold
494,403
– – 0.11% 77
2022
Q3 		$4.35M Hold
494,403
– – 0.13% 85
2022
Q2 		$3.54M Hold
494,403
– – 0.11% 86
2022
Q1 		$5.29M Sell
494,403
-178,949
-27% -$2.12M 0.11% 104
2021
Q4 		$9.47M Sell
673,352
-314,148
-32% -$6.24M 0.15% 98
2021
Q3 		$17.4M Buy
+987,500
New +$18.9M 0.25% 74

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors's TYRA Position: Q4 2024 in Review

Perceptive Advisors sold out of Tyra Biosciences (TYRA) in Q4 2024, closing a stake of 511,226 shares — an estimated $12M sold.

Perceptive Advisors first reported a position in TYRA in Q3 2021 and held it in 13 quarters. The position peaked at $17.4M in Q3 2021. 113 funds tracked by Wall St. Rank hold TYRA as of Q4 2024.

  • Perceptive Advisors reported no remaining Tyra Biosciences position as of Q4 2024 after selling out during the quarter.
  • Perceptive Advisors sold 511,226 Tyra Biosciences shares in Q4 2024, an estimated $12M.
  • Perceptive Advisors first reported a position in Tyra Biosciences in Q3 2021 and held it in 13 quarters.
  • Perceptive Advisors's Tyra Biosciences position peaked at $17.4M in Q3 2021.
  • 113 funds tracked by Wall St. Rank held Tyra Biosciences as of Q4 2024.

Based on Perceptive Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.